Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?

被引:17
作者
Anwar, Sirajudheen [1 ,2 ,3 ]
Malik, Jonaid Ahmad [4 ,5 ]
Ahmed, Sakeel [6 ]
Kameshwar, Verma Abhishek [7 ]
Alanazi, Jowaher [1 ,2 ,3 ]
Alamri, Abdulwahab [1 ,2 ,3 ]
Ahemad, Nafees [8 ]
机构
[1] Univ Hail, Coll Pharm, Dept Pharmacol & Toxicol, Hail 81422, Saudi Arabia
[2] Univ Hail, Mol Diagnost Unit, Hail 81422, Saudi Arabia
[3] Univ Hail, Personalized Treatment, Hail 81422, Saudi Arabia
[4] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Gauhati 781101, Assam, India
[5] Indian Inst Technol Ropar, Dept Biomed Engn, Rupnagar 140001, Punjab, India
[6] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Ahmadabad 382355, Gujarat, India
[7] Amrita Vishwa Vidyapeetham, Dept Pharmacol, Amrita Sch Pharm, Kochi 641112, Kerala, India
[8] Monash Univ Malaysia, Sch Pharm, Jalan Lagoon Selatan, Petaling Jaya 47500, Selangor De, Malaysia
来源
MOLECULES | 2022年 / 27卷 / 22期
关键词
epithelial-mesenchymal transition; cancer EMT; natural chemical entities; cancer; anticancer therapy; chemotherapy; EPITHELIAL-MESENCHYMAL TRANSITION; SPONGE CHONDROSIA-CORTICATA; GROWTH-FACTOR-BETA; NF-KAPPA-B; BREAST-CANCER; DOXORUBICIN RESISTANCE; MULTIDRUG-RESISTANCE; LUTEOLIN SUPPRESSES; DRUG-RESISTANCE; DOWN-REGULATION;
D O I
10.3390/molecules27227668
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is the leading cause of death and has remained a big challenge for the scientific community. Because of the growing concerns, new therapeutic regimens are highly demanded to decrease the global burden. Despite advancements in chemotherapy, drug resistance is still a major hurdle to successful treatment. The primary challenge should be identifying and developing appropriate therapeutics for cancer patients to improve their survival. Multiple pathways are dysregulated in cancers, including disturbance in cellular metabolism, cell cycle, apoptosis, or epigenetic alterations. Over the last two decades, natural products have been a major research interest due to their therapeutic potential in various ailments. Natural compounds seem to be an alternative option for cancer management. Natural substances derived from plants and marine sources have been shown to have anti-cancer activity in preclinical settings. They might be proved as a sword to kill cancerous cells. The present review attempted to consolidate the available information on natural compounds derived from plants and marine sources and their anti-cancer potential underlying EMT mechanisms.
引用
收藏
页数:20
相关论文
共 133 条
[21]   Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis [J].
Chen, Jinhua ;
Wang, Wenfang ;
Wang, Hongyuan ;
Liu, Xinyong ;
Guo, Xiuli .
DRUG DISCOVERIES AND THERAPEUTICS, 2014, 8 (01) :33-41
[22]   Turning foes to friends: targeting cancer-associated fibroblasts [J].
Chen, Xueman ;
Song, Erwei .
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (02) :99-115
[23]   Clinical and therapeutic relevance of cancer-associated fibroblasts [J].
Chen, Yang ;
McAndrews, Kathleen M. ;
Kalluri, Raghu .
NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (12) :792-804
[24]   Paeonia lactiflora Extract Attenuating Cerebral Ischemia and Arterial Intimal Hyperplasia Is Mediated by Paeoniflorin via Modulation of VSMC Migration and Ras/MEK/ERK Signaling Pathway [J].
Chen, Yuh-Fung ;
Wu, Kuo-Jen ;
Wood, W. Gibson .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
[25]   Halichondramine, a new tetracyclic bipiperidine alkaloid from the marine sponge Halichondria sp. [J].
Chill, L ;
Yosief, T ;
Kashman, Y .
JOURNAL OF NATURAL PRODUCTS, 2002, 65 (11) :1738-1741
[26]   Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights [J].
Chiu, Kuan-Jung ;
Chiou, Hsin-Ying Clair ;
Huang, Chi-Han ;
Lu, Pin-Chun ;
Kuo, Hui-Ru ;
Wang, Jiunn-Wei ;
Lin, Ming-Hong .
BIOMEDICINES, 2022, 10 (03)
[27]   AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt-MDM2-Foxo3a Signaling Axis [J].
Chou, Chih-Chien ;
Lee, Kuen-Haur ;
Lai, I-Lu ;
Wang, Dasheng ;
Mo, Xiaokui ;
Kulp, Samuel K. ;
Shapiro, Charles L. ;
Chen, Ching-Shih .
CANCER RESEARCH, 2014, 74 (17) :4783-4795
[28]   A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma [J].
Chua, Kian-Ngiap ;
Sim, Wen-Jing ;
Racine, Victor ;
Lee, Shi-Yun ;
Goh, Boon Cher ;
Thiery, Jean Paul .
PLOS ONE, 2012, 7 (03)
[29]   Inhibitory actions of berberine on growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients [J].
Chung, JG ;
Wu, LT ;
Chang, SH ;
Lo, HH ;
Hsieh, SE ;
Li, YC ;
Hung, CF .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 1999, 18 (01) :35-40
[30]   Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells [J].
D'Alesio, Carolina ;
Bellese, Grazia ;
Gagliani, Maria Cristina ;
Aiello, Cinzia ;
Grasselli, Elena ;
Marcocci, Gianluca ;
Bisio, Angela ;
Tavella, Sara ;
Daniele, Tiziana ;
Cortese, Katia ;
Castagnola, Patrizio .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36